Cancer
Conditions
Interventions
Sponsors
Osaka University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet any of the following conditions. (1) Patients who have been diagnosed with malignant tumors or suspected of having malignant tumors and have CT or FDG-PET examination. (2) Patients who have been diagnosed with malignant tumor and are scheduled to receive or have undergone anticancer treatment such as chemotherapy or radiation therapy. (3) Patients suspected of recurrence by clinical findings or diagnostic imaging such as CT or FDG-PET after treatment of malignant tumor
Exclusion criteria
Exclusion criteria: (1) Pregnant women or patients who may be pregnant (2) Pediatric patients requiring sedation (3) Those who are judged to be inappropriate as subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Comparison of the uptake on FAPI-PET with conventional imaging (CT and FDG-PET) 2) Comparison of pathological specimens obtained by surgery or biopsy with abnormal uptake on FAPI-PET 3) Time course of uptake on FAPI-PET before and after treatment compared with conventional imaging | — |
Countries
Japan
Contacts
Public ContactTadashi Watabe
Osaka University Hospital Department of Nuclear Medicine
Outcome results
None listed